D.R. Horton
DHI
Lennar Corp
LEN
KB Home
KBH
4
Petroleo Brasileiro SA Petrobras
PBR
5
Ecopetrol
EC
US Stock MarketDetailed Quotes
AGL Agilon Health
- 3.570
- +0.060+1.71%
Close Mar 10 16:00 ET
- 3.510
- -0.060-1.68%
Pre 06:16 ET
1.47BMarket Cap-5.67P/E (TTM)
3.820High3.410Low7.61MVolume3.480Open3.510Pre Close27.61MTurnover2.48%Turnover RatioLossP/E (Static)412.30MShares7.73052wk High3.13P/B1.09BFloat Cap1.50052wk Low--Dividend TTM306.46MShs Float44.830Historical High--Div YieldTTM11.68%Amplitude1.500Historical Low3.627Avg Price1Lot Size
About Agilon Health Company
Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.
Company Profile
SymbolAGL
Company NameAgilon Health
Listing DateApr 15, 2021
Issue Price23.00
Founded2016
CEOMr. Steven J. Sell
MarketNYSE
Employees1076
Fiscal Year Ends12-31
Address6210 East Highway 290,Suite 450
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78723
Phone1-562-256-3800
Websitehttp://www.agilonhealth.com
Company Executives
- Name
- Position
- Salary
- Steven J. Sell
- Chief Executive Officer, President and Director
- 5.27M
- Jeffrey A. Schwaneke
- Chief Financial Officer and Executive Vice President
- 230.00K
- Dr. Kevin Spencer, M.D.
- Chief Clinical Officer
- --
- Girish Venkatachaliah
- Chief Technology Officer
- 2.88M
- Timothy Gertsch
- Chief Accounting Officer
- --
- Veeral Desai
- Chief Strategy and Development Officer
- 3.40M
- Benjamin Shaker
- Chief Markets Officer
- 2.93M
- Dr. Karthik Rao, M.D.
- Interim Chief Medical Officer
- --
- Ravi Sachdev
- Vice Chairman of the Board
- --
- Ronald A. Williams
- Chairman of the Board
- 160.00K
- Karen A. McLoughlin
- Independent Director
- 292.50K
- Dr. John William Wulf, M.D.
- Independent Director
- 230.00K
- Silvana Battaglia
- Independent Director
- 374.85K
- Diana L. McKenzie
- Independent Director
- 405.44K
- Dr. Sharad S. Mansukani, M.D.
- Independent Director
- 245.00K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!